A4852Introduced in the General Assembly
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.
Introduced by Andrea Katz, District 8
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.
Where it stands
Approved P.L.2026, c.40.
July 8, 2026
How did lawmakers vote?
General Assembly votes
2 recorded votes · each counted separately
Senate votes
2 recorded votes · each counted separately
SenateStage: Senate Floor: Third Reading - Final Passage · June 30, 2026
38
Yes
2
No
0
Absent or Not Voting
40 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.
See how each senator voted
| Senator | District | Vote |
|---|---|---|
| Michael Testa | 1 | Yes |
| Vincent Polistina | 2 | Yes |
| John Burzichelli | 3 | Yes |
| Paul Moriarty | 4 | Yes |
| Nilsa Cruz-Perez | 5 | Yes |
| James Beach | 6 | Yes |
| Troy Singleton | 7 | Yes |
| Latham Tiver | 8 | Yes |
| Carmen Amato | 9 | Yes |
| James Holzapfel | 10 | Yes |
Bill history
Introduced, Referred to Assembly Health Committee
Transferred to Assembly State and Local Government Committee
Reported from Assembly Comm. as a Substitute, 2nd Reading
Passed by the Assembly (76-2-1)
Received in the Senate without Reference, 2nd Reading
Substituted for S4194/4210 (SCS)
Passed Senate (Passed Both Houses) (38-2)
Approved P.L.2026, c.40.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.